摘要
Brain metastasis(BM)of lung cancer is not rare in the course of tumor development.The overall survival(OS)of patients diagnosed with BM is only 3.6 months without radiotherapy.With rapid developments in treatment for BM,a median survival time(MST)of approximately 16 months could be achieved.[1]For patients with epidermal growth factor receptor mutations or anaplastic lymphoma kinase gene rearrangements,corresponding agents have been approved for treatment.In patients without driven genes mutation,radiation therapy remains the standard regimen for BM.
基金
a grant from the Postgraduate Workstation of Oncology of Guizhou Province[Qian Jiao Ke He GZZ(2016)06].
